HENDERSON JANE (Chief Financial Officer) sold 1.1% of their position (2K shares) of APOGEE THERAPEUTICS, INC. on the open market
Open‑market sale worth $131.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 2/4/2026ACC: 0001104659-26-010453
Officer· Chief Financial Officer
Since Mar 2026
-2K
Net shares
Net seller
$131.6K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
2K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−792.00
Price / share
$65.21
Trade value
$51.65K
% of position
0.4%
2/2/2026
185.37K→184.58K
Common Stock
Direct
Shares
−1.11K
Price / share
$66.15
Trade value
$73.29K
% of position
0.6%
2/2/2026
184.58K→183.47K
Common Stock
Direct
Shares
−100.00
Price / share
$66.89
Trade value
$6.69K
% of position
0.1%
2/2/2026
183.47K→183.37K
Total
Net shares
−2K
Net value
-$131.63K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/2/2026 | S · Sale | −792.00 | $65.21 | $51.65K | 0.4% | 185.37K | 184.58K |
| Common Stock Direct | 2/2/2026 | S · Sale | −1.11K | $66.15 | $73.29K | 0.6% | 184.58K | 183.47K |
| Common Stock Direct | 2/2/2026 | S · Sale | −100.00 | $66.89 | $6.69K | 0.1% | 183.47K | 183.37K |
| Total | −2K | -$131.63K | ||||||
Derivative Transactions0
No derivative transactions reported